Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Natco Pharma

Tracked across 7 events · 48 articles · First seen Mar 20, 2025 · Last active Aug 25, 2026

Sentiment
34
Attention
6
Events
7
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 -40
Business
Impact: Natco Pharma is the reporting company; its Q1 results show a significant profit decline due to lower lenalidomide sales, impacting its financial performance and market perception.
Aug 14, 2026 · 6 articles
2 30
Business
Impact: Natco Pharma is the investor, committing $14 million to eGenesis, increasing its total stake to $22 million. The investment aligns with its strategy to diversify into advanced therapeutics, though its stock fell 1.92% on the day.
Aug 25, 2026 · 6 articles
6 80
Business
Impact: Natco Pharma is a key player in launching generic semaglutide in India at a significantly lower price, aiming to capture a substantial share of the weight-loss drug market.
Mar 20, 2026 · 8 articles
2 50
Business
Impact: Natco Pharma, in alliance with Lupin (company), secured U.S. FDA approval for its Abbreviated New Drug Application for Eribulin Mesylate Injection, enhancing its oncology portfolio and market presence.
Jun 03, 2026 · 8 articles
3 50
Regulatory
Impact: NATCO will manufacture the generic Olaparib tablets. The tentative approval enhances its manufacturing portfolio and partnership with Alembic.
Jul 19, 2026 · 6 articles
4 20
Business
Impact: Natco Pharma is one of several Indian companies that launched generic versions of semaglutide, increasing competition for Novo Nordisk.
Mar 30, 2026 · 8 articles
2 50
Business
Impact: Natco Pharma continues to be an investor in Pee Safe.
Mar 17, 2026 · 6 articles
India ↔ Natco Pharma
India ↔ Natco Pharma
ERGEN INTELLIGENCE
Track Natco Pharma live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.